These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36445035)

  • 1. Body mass index and molecular subtypes of colorectal cancer.
    Murphy N; Newton CC; Song M; Papadimitriou N; Hoffmeister M; Phipps AI; Harrison TA; Newcomb PA; Aglago EK; Berndt SI; Brenner H; Buchanan DD; Cao Y; Chan AT; Chen X; Cheng I; Chang-Claude J; Dimou N; Drew D; Farris AB; French AJ; Gallinger S; Georgeson P; Giannakis M; Giles GG; Gruber SB; Harlid S; Hsu L; Huang WY; Jenkins MA; Laskar RS; Le Marchand L; Limburg P; Lin Y; Mandic M; Nowak JA; Obón-Santacana M; Ogino S; Qu C; Sakoda LC; Schoen RE; Southey MC; Stadler ZK; Steinfelder RS; Sun W; Thibodeau SN; Toland AE; Trinh QM; Tsilidis KK; Ugai T; Van Guelpen B; Wang X; Woods MO; Zaidi SH; Gunter MJ; Peters U; Campbell PT
    J Natl Cancer Inst; 2023 Feb; 115(2):165-173. PubMed ID: 36445035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses.
    Papadimitriou N; Qu C; Harrison TA; Bever AM; Martin RM; Tsilidis KK; Newcomb PA; Thibodeau SN; Newton CC; Um CY; Obón-Santacana M; Moreno V; Brenner H; Mandic M; Chang-Claude J; Hoffmeister M; Pellatt AJ; Schoen RE; Harlid S; Ogino S; Ugai T; Buchanan DD; Lynch BM; Gruber SB; Cao Y; Hsu L; Huyghe JR; Lin Y; Steinfelder RS; Sun W; Van Guelpen B; Zaidi SH; Toland AE; Berndt SI; Huang WY; Aglago EK; Drew DA; French AJ; Georgeson P; Giannakis M; Hullar M; Nowak JA; Thomas CE; Le Marchand L; Cheng I; Gallinger S; Jenkins MA; Gunter MJ; Campbell PT; Peters U; Song M; Phipps AI; Murphy N
    EBioMedicine; 2024 Mar; 101():105010. PubMed ID: 38350331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of BMI and major molecular pathological markers of colorectal cancer in men and women.
    Carr PR; Amitay EL; Jansen L; Alwers E; Roth W; Herpel E; Kloor M; Schneider M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    Am J Clin Nutr; 2020 Mar; 111(3):562-569. PubMed ID: 31897467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors and Incidence of Colorectal Cancer According to Major Molecular Subtypes.
    Wang L; He X; Ugai T; Haruki K; Lo CH; Hang D; Akimoto N; Fujiyoshi K; Wang M; Fuchs CS; Meyerhardt JA; Zhang X; Wu K; Chan AT; Giovannucci EL; Ogino S; Song M
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
    Amitay EL; Carr PR; Jansen L; Walter V; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    J Natl Cancer Inst; 2019 May; 111(5):475-483. PubMed ID: 30388256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.
    Phipps AI; Alwers E; Harrison T; Banbury B; Brenner H; Campbell PT; Chang-Claude J; Buchanan D; Chan AT; Farris AB; Figueiredo JC; Gallinger S; Giles GG; Jenkins M; Milne RL; Newcomb PA; Slattery ML; Song M; Ogino S; Zaidi SH; Hoffmeister M; Peters U
    Gastroenterology; 2020 Jun; 158(8):2158-2168.e4. PubMed ID: 32088204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.
    Mehta RS; Song M; Nishihara R; Drew DA; Wu K; Qian ZR; Fung TT; Hamada T; Masugi Y; da Silva A; Shi Y; Li W; Gu M; Willett WC; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
    Gastroenterology; 2017 Jun; 152(8):1944-1953.e1. PubMed ID: 28249812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer.
    Nagasaka T; Koi M; Kloor M; Gebert J; Vilkin A; Nishida N; Shin SK; Sasamoto H; Tanaka N; Matsubara N; Boland CR; Goel A
    Gastroenterology; 2008 Jun; 134(7):1950-60, 1960.e1. PubMed ID: 18435933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Smoking and Molecular Subtypes of Colorectal Cancer.
    Wang X; Amitay E; Harrison TA; Banbury BL; Berndt SI; Brenner H; Buchanan DD; Campbell PT; Cao Y; Chan AT; Chang-Claude J; Gallinger SJ; Giannakis M; Giles GG; Gunter MJ; Hopper JL; Jenkins MA; Lin Y; Moreno V; Nishihara R; Newcomb PA; Ogino S; Phipps AI; Sakoda LC; Schoen RE; Slattery ML; Song M; Sun W; Thibodeau SN; Toland AE; Van Guelpen B; Woods MO; Hsu L; Hoffmeister M; Peters U
    JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34377935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathways.
    Amitay EL; Carr PR; Jansen L; Alwers E; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    Int J Cancer; 2020 Aug; 147(4):1018-1026. PubMed ID: 31943160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status.
    Myte R; Gylling B; Häggström J; Häggström C; Zingmark C; Löfgren Burström A; Palmqvist R; Van Guelpen B
    Int J Cancer; 2019 Jul; 145(2):327-337. PubMed ID: 30613980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability.
    Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F
    Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intake of Dietary Fruit, Vegetables, and Fiber and Risk of Colorectal Cancer According to Molecular Subtypes: A Pooled Analysis of 9 Studies.
    Hidaka A; Harrison TA; Cao Y; Sakoda LC; Barfield R; Giannakis M; Song M; Phipps AI; Figueiredo JC; Zaidi SH; Toland AE; Amitay EL; Berndt SI; Borozan I; Chan AT; Gallinger S; Gunter MJ; Guinter MA; Harlid S; Hampel H; Jenkins MA; Lin Y; Moreno V; Newcomb PA; Nishihara R; Ogino S; Obón-Santacana M; Parfrey PS; Potter JD; Slattery ML; Steinfelder RS; Um CY; Wang X; Woods MO; Van Guelpen B; Thibodeau SN; Hoffmeister M; Sun W; Hsu L; Buchanan DD; Campbell PT; Peters U
    Cancer Res; 2020 Oct; 80(20):4578-4590. PubMed ID: 32816852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases.
    Harlid S; Van Guelpen B; Qu C; Gylling B; Aglago EK; Amitay EL; Brenner H; Buchanan DD; Campbell PT; Cao Y; Chan AT; Chang-Claude J; Drew DA; Figueiredo JC; French AJ; Gallinger S; Giannakis M; Giles GG; Gunter MJ; Hoffmeister M; Hsu L; Jenkins MA; Lin Y; Moreno V; Murphy N; Newcomb PA; Newton CC; Nowak JA; Obón-Santacana M; Ogino S; Potter JD; Song M; Steinfelder RS; Sun W; Thibodeau SN; Toland AE; Ugai T; Um CY; Woods MO; Phipps AI; Harrison T; Peters U
    Int J Cancer; 2022 Aug; 151(3):348-360. PubMed ID: 35383926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study.
    Brändstedt J; Wangefjord S; Nodin B; Eberhard J; Sundström M; Manjer J; Jirström K
    PLoS One; 2014; 9(2):e98964. PubMed ID: 24918610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonoscopy and Reduction of Colorectal Cancer Risk by Molecular Tumor Subtypes: A Population-Based Case-Control Study.
    Hoffmeister M; Bläker H; Jansen L; Alwers E; Amitay EL; Carr PR; Kloor M; Herpel E; Roth W; Chang-Claude J; Brenner H
    Am J Gastroenterol; 2020 Dec; 115(12):2007-2016. PubMed ID: 32858564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.
    Murcia O; Juárez M; Rodríguez-Soler M; Hernández-Illán E; Giner-Calabuig M; Alustiza M; Egoavil C; Castillejo A; Alenda C; Barberá V; Mangas-Sanjuan C; Yuste A; Bujanda L; Clofent J; Andreu M; Castells A; Llor X; Zapater P; Jover R
    PLoS One; 2018; 13(9):e0203051. PubMed ID: 30188916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.
    Limsui D; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Harnack LJ; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ
    J Natl Cancer Inst; 2010 Jul; 102(14):1012-22. PubMed ID: 20587792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort.
    Chen KH; Lin LI; Yuan CT; Tseng LH; Chao YL; Liang YH; Liang JT; Lin BR; Cheng AL; Yeh KH
    Br J Cancer; 2021 Jul; 125(1):48-54. PubMed ID: 33846524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
    Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
    Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.